Doxylamine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

H1 antagonist.

Spectrum of actionThis section has been translated automatically.

H1 antagonist.

IndicationThis section has been translated automatically.

Allergic reactions.

Dosage and method of useThis section has been translated automatically.

  • 1-3 times 25 mg/day p.o.
  • Children 6-14 years: 1-2 times 25 mg/day p.o.

Undesirable effectsThis section has been translated automatically.

Paragroup allergy (mereprine syrup), exanthema, sedation, central nervous disorders, agitation states in infants, visual disorders, narrow-angle glaucoma, dry mouth, gastrointestinal disorders, BB changes, micturition disorders, hypersensitivity reactions, rhabdomyolysis after overdose.

InteractionsThis section has been translated automatically.

Enhancement of the effect by centrally attenuating drugs and alcohol.

ContraindicationThis section has been translated automatically.

Pregnancy, lactation, prostate hypertrophy, narrow angle glaucoma, paragroup allergy (mereprine syrup).

PreparationsThis section has been translated automatically.

Hoggar, Mereprine, Sedaplus

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer